logo

Immune Globulins and Autism Ranking: Mildly Hazardous Limited negative evidence

Future Research

Summary of Existing Research

  • There is some evidence of a link between immune deficiency disorders and some autistic people but the nature of that link is unclear. 
  • There is no high quality research evidence to suggest that immunoglobulin therapy has any effect on the core symptoms of autism.
  • There is a limited amount of high quality research evidence (a single, large, multi-site randomised controlled trial) to suggest that immunoglobulin therapy has no effect on bowel disorders in autistic individuals.

Recommendations for Future Research

At this stage research into the use of immune globulin as an intervention for autistic people is not a priority.

Updated
16 Jun 2022
Last Review
31 May 2018
Next Review
01 Jun 2024